You like $ISRG, $JNJ, $MDT or are a Healthcare/Medtech investor?

$SUS Surgical Science is quietly building one of the most exciting software companies in Medtech and is set to grow exponentially over the next decade!
🧵
Find out why you should know about $SUS $SUS.ST
👇👇 1/ Overview

SUS supplies software that is embedded in robotic surgery training platforms and to universities. This comes with very attractive economics.

Revenue have grown at a >40% CAGR over the last 5Y and EBITDA margins were >30%.

Still, the growth phase is just beginning.

💊🔬🩸
Medtech and biotechnology benefit from key secular growth trends.
📈📊💵
An aging population, new innovative therapies and increasing testing requirements, some businesses with be able to grow profits for a long time.

This thread will focus on a few beneficiaries
🧵
👇👇 $MEDI Medistim 🇳🇴

📊Sales CAGR: 10%
📈EBIT Margin: 25%
💰ROIC: 28%

Medistim provides medical imaging technology for heart surgeries. It benefits from a strong market position and its solutions are growing in popularity in the US.

Today, I present a list of marketplace businesses. Classifieds & marketplace benefit from network effects and tend to be attractive businesses for investors.

What is your favourites marketplace business and which ones have I missed?

🧵
👇👇 🇺🇸CoStar Group $CSGP

📊Sales CAGR: 18%
📈EBIT Margin: ~20%
💰ROIC: 15-20% at maturity

Half of CSGP's revenues are from marketplaces in the real estate market. CSGP operates multiple marketplaces to rent&sell properties.
yhamiltonblog.substack.com/p/agb-202121-c…

I call them "key component companies". They are a tiny % of total costs but deliver a tremendous amount of value. This often leads to pricing power and good returns on capital.

Today, I will share 14 of those companies. 🧵

Which other companies fit these criteria?
👇👇👇 $GIVN Givaudan🇨🇭

📊Gross Margin: 40%
📈EBIT Margin: 16%
💰ROIC: 15%

Flavours & fragrances only make up ~1% of total product costs but are essential to the appeal to consumers. This enables GIVN to charge a premium for services where the price is not a primary consideration.

Today I present you a list of 24 serial acquirers the average investor hasn't heard of.

The data presented is for the last 5 years.

Will any of them become the next $CSU, $DHR, $TDG, $HEI or even $TMO?
Time for a thread 🧵
👇👇👇 $VIT Vitec Software 🇸🇪

Mkt cap: $2B

📊Sales CAGR: 18.4%
💰FCF CAGR: 25,7%
📈Tot Return p.a.: 50%

With >30 VMS businesses acquired, this company could be considered the Constellation Software of the Nordics. You can read my in-depth analysis here:
partnershipinvesting.substack.com/p/vitec-softwa…

🧵 about one of the best serial acquirers

🔬Judges Scientific $JDG.LN $JDG

Judges Scientific delivered a 26% annual shareholder return since 2003 vs 8.5% for the FTSE All-Share

Here is how👇 2/ History

Judges Scientific started as Judges Capital, an investment vehicle started by PE veteran David Cicurel to buy out undervalued public companies.